PRESS RELEASE published on 12/17/2025 at 22:05, 7 months 21 days ago Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings Abivax announces acceptance of 22 abstracts evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, featuring oral presentation on preclinical anti-fibrotic findings Abivax Obefazimod Preclinical Study Inflammatory Bowel Disease ECCO 2026
BRIEF published on 12/15/2025 at 22:10, 7 months 23 days ago Abivax: Third Quarter 2025 Financial Results Financial Results Treasury Abivax Net Loss R&D Expenditures
BRIEF published on 12/15/2025 at 22:10, 7 months 23 days ago Abivax : Résultats financiers du troisième trimestre 2025 Résultats Financiers Abivax Trésorerie Perte Nette Dépenses R&D
BRIEF published on 12/15/2025 at 22:10, 7 months 23 days ago Abivax publie ses résultats financiers du troisième trimestre 2025 Dépenses De R&D Financement Des Biotechnologies Abivax Financials Résultats Du Troisième Trimestre 2025 Position De Trésorerie
BRIEF published on 12/15/2025 at 22:10, 7 months 23 days ago Abivax Reports Third Quarter 2025 Financial Results Cash Position Biotech Funding R&D Expenses Q3 2025 Results Abivax Financials
PRESS RELEASE published on 12/15/2025 at 22:05, 7 months 23 days ago Abivax présente ses résultats financiers du troisième trimestre 2025 Abivax présente ses résultats financiers du troisième trimestre 2025 avec trésorerie de 589,7 millions d'euros et une autonomie financière jusqu'au quatrième trimestre 2027 Résultats Financiers Abivax Troisième Trimestre Autonomie Financière 589,7 Millions D'euros
PRESS RELEASE published on 12/15/2025 at 22:05, 7 months 23 days ago Abivax Presents Third Quarter 2025 Financial Results Abivax presents its third quarter 2025 financial results with EUR 589.7 cash and cash equivalents, providing key updates on its business and operational goals Financial Results Abivax Third Quarter Operational Goals Cash Equivalents
BRIEF published on 12/12/2025 at 18:05, 7 months 26 days ago ABIVAX : Publication des Données Capital et Droits de Vote au 30 Novembre 2025 Droits De Vote Capital Social Abivax Réglementation AMF Informations Financières
BRIEF published on 12/12/2025 at 18:05, 7 months 26 days ago ABIVAX: Publication of Capital and Voting Rights Data as of November 30, 2025 Financial Information Share Capital Voting Rights Abivax AMF Regulations
PRESS RELEASE published on 12/12/2025 at 18:00, 7 months 26 days ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.11.25. ABIVAX révèle le nombre d'actions et de droits de vote au 30.11.25 conformément à la réglementation financière. Détails disponibles dans le communiqué officiel Droits De Vote Actions Abivax Réglementation Communiqué
Published on 08/07/2026 at 23:15, 27 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 42 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 1 hour 12 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 1 hour 27 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/07/2026 at 14:17, 9 hours 25 minutes ago NuRAN Wireless Increases Series A Preferred Share Financing to C$7.6 Million and Announces Debt Settlements
Published on 08/07/2026 at 23:21, 21 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 4 hours 12 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 4 hours 27 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 5 hours 32 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 5 hours 42 minutes ago E-PANGO: Composition du capital au 31 juillet 2026
Published on 08/07/2026 at 18:54, 4 hours 48 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 4 hours 48 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 5 hours 2 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 5 hours 2 minutes ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 5 hours 42 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
